6 Results

People

  1. Boyer
    Boyer
  2. Cao
    Cao
  3. Chandarlapaty
    Chandarlapaty
  4. Cho
    Cho
  5. De Stanchina
    De Stanchina
  6. Del Priore
    Del Priore
  7. Dorso
    Dorso
  8. Feng
    Feng
  9. Hagen
    Hagen
  10. Hayatt
    Hayatt

Groups

  1. Alumni (GSK) (4)
  2. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (4)
  3. MSK Grad Students (4)
  4. Sloan Kettering Institute Postdocs (4)
  5. GSK Faculty (3)
  6. Department of Pathology and Laboratory Medicine (2)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  8. Basic Research Innovation Award (BRIA) (1)
  9. Breast Medicine Service (1)
  10. Center for Molecular Imaging and Biotechnology (1)
  1. "foxa1"
Formats
  1. Journal Article (6)
Groups
  1. Alumni (GSK) (4)
  2. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (4)
  3. MSK Grad Students (4)
  4. Sloan Kettering Institute Postdocs (4)
  5. GSK Faculty (3)
  6. Department of Pathology and Laboratory Medicine (2)

More Groups

People
  1. Amanda Kulick (1)
  2. Britta Weigelt (1)
  3. Christina Leslie (1)
  4. Connor Hagen (1)
  5. Danwei Huangfu (1)
  6. Elisa De Stanchina (1)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
  3. 2019 (2)
Publications
  1. American Journal of Cancer Research (1)
  2. Cancer Cell (1)
  3. Cancer Research Communications (1)
  4. Cell Reports (1)
  5. Molecular Oncology (1)
  6. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. Cell Press (2)
  2. American Association for Cancer Research (1)
  3. FEBS Press (1)
  4. National Academy of Sciences (1)
  5. e-Century Publishing Corporation (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A druggable FOXA1-glucocorticoid receptor transcriptional axis drives tumor growth in a subset of non-small cell lung cancer
    Journal Article

    Dorso, M.; Patel, P. T.; Pankov, A.; Boyer, J. A.; Soni, R. K.; Del Priore, I. S.; Hayatt, O.; Kulick, A.; Hagen, C. J.; de Stanchina, E.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
    Journal Article

    Celada, S. I.; Li, G.; Celada, L. J.; Lu, W.; Kanagasabai, T.; Feng, W.; Cao, Z.; Salsabeel, N.; Mao, N.; Brown, L. K.; more...
    Molecular Oncology (2023)

    Fulltext@MSK | Save
  • Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
    Journal Article

    Li, X.; Wang, Y.; Deng, S.; Zhu, G.; Wang, C.; Johnson, N. A.; Zhang, Z.; Tirado, C. R.; Xu, Y.; Metang, L. A.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Identification of novel biomarkers differentially expressed between African-American and Caucasian-American prostate cancer patients
    Journal Article

    Ye, F.; Han, X.; Shao, Y.; Lo, J.; Zhang, F.; Wang, J.; Melamed, J.; Deng, F. M.; Sfanos, K. S.; De Marzo, A.; more...
    American Journal of Cancer Research (2022)

    Fulltext@MSK | Save
  • FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
    Journal Article

    Fu, X.; Pereira, R.; De Angelis, C.; Veeraraghavan, J.; Nanda, S.; Qin, L.; Cataldo, M. L.; Sethunath, V.; Mehravaran, S.; Gutierrez, C.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2019)

    Fulltext@MSK | Save
  • FOXA2 is required for enhancer priming during pancreatic differentiation
    Journal Article

    Lee, K.; Cho, H.; Rickert, R. W.; Li, Q. V.; Pulecio, J.; Leslie, C. S.; Huangfu, D.
    Cell Reports (2019)

    Fulltext@MSK | Save